newsfilter
← Latest News
GlobeNewswire·

Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules

DENVER, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC:MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today annou